# A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

> **NCT06798012** · PHASE2 · RECRUITING · sponsor: **Takeda** · enrollment: 36 (estimated)

## Conditions studied

- Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

## Interventions

- **BIOLOGICAL:** TAK-411

## Key facts

- **NCT ID:** NCT06798012
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-14
- **Primary completion:** 2027-12-02
- **Final completion:** 2028-06-08
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06798012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06798012, "A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06798012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*